MedPath

Innovative Digital Therapeutic for Smoking Cessation

Not Applicable
Completed
Conditions
Nicotine Addiction
Tobacco Dependence
Smoking Cessation
Drug Addiction
Substance Use Disorder
Tobacco Smoking
Tobacco Use Disorder
Drug Dependence
Interventions
Device: QuitGuide
Device: CT-101-M
Registration Number
NCT03694327
Lead Sponsor
My Digital Study
Brief Summary

This study is comparing the efficacy of two smoking cessation apps.

Detailed Description

Given that tobacco smoking is the leading cause of preventable death in the US, the development of effective cessation programs is critical; mobile phone applications represent a novel, accessible platform for helping smokers quit. This research project seeks to compare the efficacy of two smoking cessation apps. In a blinded, randomized, controlled study, current smokers motivated to quit will use a smoking cessation app for 8 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
158
Inclusion Criteria
  • Male or female age 18 to 65
  • Fluent in written and spoken English (confirmed by ability to read and comprehend Informed Consent Form)
  • Lives in the United States
  • Smokes at least 5 cigarettes daily
  • Is interested in quitting in the next 30 days
  • The participant owns and has access to an iPhone with iOS 9 or greater capabilities, or an Android with OS 7 or greater capabilities
  • The participant is willing and able to receive SMS text messages on their smartphone
  • The participant is willing and able to receive email messages.
  • Ability to confirm download of installed treatment arm app via telephone on randomization date.
  • One half of the study sample will be recruited from the general population of smokers via social media advertisements
  • One half of the study sample will be recruited via mail form a Magellan Behavioral Health value-based care network
Exclusion Criteria
  • Prior use of Treatment A Digital Intervention or Treatment B Digital Intervention
  • Current use of pharmacotherapy for smoking cessation or nicotine replacement therapy (NRT)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment B Mobile ApplicationQuitGuideTreatment B Digital Intervention: Smartphone application designed to assist with smoking cessation.
Treatment A Mobile ApplicationCT-101-MTreatment A Digital Intervention: Smartphone application designed to assist with smoking cessation.
Primary Outcome Measures
NameTimeMethod
30-Day Sustained Abstinence From SmokingUpon completion of 8-week period

Self-reported abstinence from smoking was assessed in the 8-Week Outcome Survey.

Secondary Outcome Measures
NameTimeMethod
Feasibility of Biochemical Verification of Smoking CessationUpon completion of 8-week period

Confirmation with the remote CO assessment was conducted to assess concordance between self-report and remote CO assessment results. Abstinence as per the CO assessment was defined as an iCO reading of fewer than 7ppm exhaled CO.

NRT and Smoking Cessation Pharmacotherapy UseUpon completion of 8-week period

Self-reported NRT and smoking cessation pharmacotherapy use will be acquired via the outcome survey. Cessation rates will be compared between those using/not using pharmacotherapy.

Trial Locations

Locations (1)

My Digital Study

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath